Turn Therapeutics Inc.
TTRX · XNASCIK 2023016fmd_1SYEFW71W66D1CNHF7TD668RXCManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2024 to Sep 30, 2026, 9 periods
Latest annual · FY2025
Millions- Operating income
- (6)
- Net income
- (3)
Latest quarter · Q3 FY2026
Millions- Operating income
- (2)
- Net income
- (6)
Turn Therapeutics Inc. (TTRX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$5.9 million | -$1.8 million | 10-K 2026-03-31 · proof | |
| Net income | -$3.2 million | -$1.8 million | 10-K 2026-03-31 · proof | |
| Cash from operating activities | -$2.6 million | -$1.4 million | 10-K 2026-03-31 · proof | |
| Total assets | $12.2 million | $2 million | +493.6% | 10-K 2026-03-31 · proof |
| Total liabilities | $7.5 million | $2.2 million | +235.8% | 10-K 2026-03-31 · proof |
| Cash and cash equivalents | $4 million | $498,286 | +708.3% | 10-K 2026-03-31 · proof |
- What was Turn Therapeutics Inc. (TTRX)'s operating income in fiscal 2025?
- Turn Therapeutics Inc. (TTRX) reported operating income of -$5.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.8 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Turn Therapeutics Inc. (TTRX)'s net income in fiscal 2025?
- Turn Therapeutics Inc. (TTRX) reported net income of -$3.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.8 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What was Turn Therapeutics Inc. (TTRX)'s cash from operating activities in fiscal 2025?
- Turn Therapeutics Inc. (TTRX) reported cash from operating activities of -$2.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$1.4 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Turn Therapeutics Inc. (TTRX)'s total assets?
- As of Dec 31, 2025, Turn Therapeutics Inc. (TTRX) reported total assets of $12.2 million, against $2 million a year earlier (+493.6%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Turn Therapeutics Inc. (TTRX)'s total liabilities?
- As of Dec 31, 2025, Turn Therapeutics Inc. (TTRX) reported total liabilities of $7.5 million, against $2.2 million a year earlier (+235.8%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
- What are Turn Therapeutics Inc. (TTRX)'s cash and cash equivalents?
- As of Dec 31, 2025, Turn Therapeutics Inc. (TTRX) reported cash and cash equivalents of $4 million, against $498,286 a year earlier (+708.3%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:TTRX&period_type=annual&limit=5"Information only, not investment advice.